FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved RFK Jr. & claimed regenerative peptides like BPC 157 The Niche Peptides are unproven as health aids. FDA may unleash them anyway